Comprehensive analysis of tumour mutational burden and its clinical significance in prostate cancer

The tumorigenesis of prostate cancer involves genetic mutations. Tumour mutational burden (TMB) is an emerging biomarker for predicting the efficacy of immunotherapy.

Source: BMC Urology - February 25, 2021 Category: Urology & Nephrology Authors: Lijuan Wang, Shucheng Pan, Binbin Zhu, Zhenliang Yu and Wei Wang Tags: Research article Source Type: research